cripto is the original member of the family of EGF-CFC genes, recently recognized as novel extracellular factors essential for vertebrate development. During the early stages of mouse gastrulation, cripto mRNA is detected in mesodermal cells; later, cripto mRNA is detected only in the truncus arteriosus of the developing heart. Here we describe the in vivo distribution of Cripto protein throughout mouse embryo development and show that cripto mRNA and protein colocalize. By means of immuno¯uorescence analysis and biochemical characterization, we show that Cripto is a membrane-bound protein anchored to the lipid bilayer by a glycosylphosphatidylinositol (GPI) moiety. We suggest that presentation of Cripto on the cell surface via a GPI-linkage is important in determining the spatial speci®city of cell±cell interactions that play a critical role in the early patterning of the embryo. q
Introduction
The generation of a complex three-dimensional pattern in development requires that molecules transmit accurate spatial information between cells. The signalling cells act as organizing centres that produce diffusible morphogens; different responses are induced in target cells depending on their distance from the organizer and the signal concentration to which they are exposed (Hogan et al., 1994; Perrimon and McMahon, 1999) . Over the past years, considerable progress has been made in identifying the signalling molecules (growth factors) that mediate embryonic induction in both vertebrates and invertebrates (Hogan et al., 1994) . Although the ®rst identi®ed growth factors were soluble molecules, it is now apparent that many peptide growth factors are not freely diffusible. The biological role of transmembrane anchoring of such signalling ligands is not yet clear but may include a tight localization of ligand activity or may be related to the ability of these molecules to mediate cell±cell adhesion and promote cell migration (Massague Â and Pandiella, 1993) . Still other ligands are anchored in the extracellular or pericellular matrix by interaction with molecules such as proteoglycans (David, 1993; Rapraeger et al., 1994) .
EGF-CFC proteins have recently been recognized as a novel class of extracellular factors essential for early vertebrate development (Ding et al., 1998; Zhang et al., 1998; Xu et al., 1999) . The EGF-CFC proteins include mouse Cripto (Dono et al., 1993) , Xenopus FRL1 (Kinoshita et al., 1995) , mouse Cryptic (Shen et al., 1997) and zebra®sh Oep (Zhang et al., 1998) ; all contain a signal sequence, a characteristic EGF-like domain, a second cysteine-rich region called the CFC domain, and a hydrophobic C terminus. They share an overall sequence identity of only 22±32%; however, this level of sequence identity increases to 49±62% if only the EGF-like and the CFC regions are considered in the comparison. The cripto cDNA encodes a protein of 171 amino-acids with a predicted molecular mass of 18 kDa and containing a 20-amino-acid hydrophobic stretch indicative of a signal peptide (Dono et al., 1993) . In situ hybridization experiments showed that cripto is expressed in the entire ectoderm of the implanting embryo (Johnson et al., 1994) , in the posterior ectoderm, giving rise to the primitive streak, and in the differentiating mesodermal cells of gastrulating mouse embryos (Dono et al., 1993; Ding et al., 1998) ; later in development, cripto is only detectable in the truncus arteriosus of the developing heart (Dono et al., 1993; Ding et al., 1998) . However, no data are yet available on the location of endogenous Cripto protein. In this paper, we have used immunopuri®ed anti-Cripto (a-Cripto) antibodies in immunohistochemical assays to study Cripto protein distribution during the early phase of mouse development. These data represent the ®rst description of the in vivo distribution of the endogenous product of a member of the EGF-CFC gene family. In the mouse embryo, the cripto gene is required for proper anterior±posterior axis polarity (Ding et al., 1998; Xu et al., 1999) . Furthermore, the absence of Cripto resulted in a defective precardiac mesoderm, unable to differentiate into functional cardiomyocytes (Xu et al., 1998) . Interestingly, it has recently been shown that overexpression of Cripto can rescue the maternal-zygotic (MZ) oep mutant in zebra®sh (Gritsman et al., 1999) . Whereas Oep has been described as a membrane-anchored protein (Zhang et al., 1998) acting autonomously in the formation of multiple cell types (Gritsman et al., 1999) , Cripto has been suggested to be a soluble protein acting as a non-autonomous signal (Brandt et al., 1994; Salomon et al., 1999) . To clarify this issue, we performed immunolocalization and biochemical analyses of Cripto.
Here we report that Cripto is a membrane-bound protein; moreover, since its association with the membrane is susceptible to cleavage with bacterial PI-PLC, we conclude that Cripto is anchored in the lipid bilayer by a glycosyl-PI lipid modi®cation. This is the ®rst indication that a member of the EGF-CFC family undergoes glycosylphosphatidylinositol (GPI) modi®cation.
Results
2.1. cripto mRNA and protein colocalize during early murine development cripto is expressed in a highly restricted pattern during vertebrate development. In situ hybridization experiments detected cripto transcripts in mesodermal cells at the early gastrula stages (early streak stage; Dono et al., 1993; Ding et al., 1998) . At mid-late streak stages, cripto mRNA was present in all the mesodermal cells as well as in the ectodermal cells close to the primitive streak (Dono et al., 1993) . In 8.5±10.5 dpc mouse embryos, cripto expression was restricted to the truncus arteriosus of the developing heart (Dono et al., 1993) .
It had been hypothesized that the cripto gene product is secreted and could be distributed to different regions of the embryo (Dono et al., 1993) . To evaluate Cripto protein distribution during mouse embryo development, we performed immunohistochemical analysis on embryo sections using an af®nity-puri®ed a -Cripto antiserum raised against the full-length Cripto protein (Section 4). To compare cripto mRNA and protein distribution, we performed in situ hybridization experiments on adjacent sections using a cripto probe. The distribution of cripto mRNA and protein was analysed both in transverse and sagittal sections of mouse embryos at 6.7 dpc (Figs. 1 and 2) and 8.5 dpc (Fig. 2) .
At 6.7 dpc, Cripto immunoreactivity overlaps precisely with cripto mRNA, which accumulates in the most posterior part of the embryo where cells are committed to form mesoderm (Figs. 1A, B,C and 2A,D,G) . No signi®cant immunoreactivity signal was observed when the af®nity-puri®ed antiserum was reacted with cripto 2/2 embryo sections at 6.7 dpc (Figs. 1E and 2E) , thus demonstrating the speci®city of the a -Cripto antibody. Immuno¯uorescence experiments performed on embryo sections at 6.7 dpc detected Cripto in the region of the cell surface (Fig. 2H) .
At 8.5 dpc cripto mRNA and protein were restricted to the cells of the developing truncus arteriosus (Fig. 2C,F,I ). At this stage, Cripto immunoreactivity was restricted to the myocardium in the bulbus cordis region of the primitive heart (Fig. 2C,F,I ), again precisely overlapping the mRNA distribution.
2.2.
Cripto protein is localized to the cell membrane in F9 and embryonal stem (ES) cell lines cripto is strongly expressed in undifferentiated F9 (Dono et al., 1993) and ES cells (data not shown). The predicted structure of Cripto protein strongly suggests that it is a membrane-bound protein (see below). To assess this hypothesis and to determine the subcellular location of Cripto, we performed immunostaining analysis on F9 and ES cells using the af®nity-puri®ed a -Cripto antiserum (Fig.  3A HH ,C HH ). An immunoreactivity signal was detected both in F9 and ES cells. Cells were not permeabilized and the Cripto antigen could only be detected at the cell membrane. These results suggested that Cripto is a membrane-associated protein. The speci®city of Cripto immunoreactivity was demonstrated using the mutant cripto 2/2 H32 cell line (Fig. 3B HH ). As further con®rmation, we performed Western blot analysis on total cell lysates prepared from ES cells, F9 cells and mutant cripto 2/2 H32 cells. A speci®c band (23 kDa) was detected in the protein extracts of ES and F9 cells but not in cell lysates from the cripto 2/2 H32 cell line (Fig. 3D ).
Cripto is anchored to the cell membrane by a GPI lipid moiety
Many membrane proteins are anchored to the plasma membrane by a GPI lipid anchor attached to their COOHterminal amino-acid (Ferguson and Williams, 1988) . These proteins are synthesized as a precursor with a COOH-terminal hydrophobic amino-acid extension, cleaved shortly before the transferring of the GPI lipid moiety onto the processed polypeptide (Ferguson and Williams, 1988) . The Cripto amino-acid sequence contains the two consensus structural characteristics for this secondary protein modi®-cation: (i) a C-terminal hydrophobic region required for membrane attachment of the protein; (ii) a sequence match-ing the consensus for GPI cleavage and attachment. This latter consensus sequence consists of a tri-peptide with small amino-acids (Ser, Ala, Gly, Asp, Asn, or Cys) in the ®rst and third position, located 7±20 amino-acids upstream of a carboxy-terminal hydrophobic domain (Coyne et al., 1993) ; candidate sequences are present either at residues 133±135 (Cys-Asp-Gly) or 139±141 (Asp-Gln-Asp) of Cripto (Dono et al., 1993) .
To test our hypothesis that Cripto is anchored to the membrane through a GPI linkage, we assayed both the requirement for a hydrophobic C-terminus and the susceptibility to cleavage by phosphatidylinositol phospholipase C (PI-PLC).
The hydrophobic C-terminal domain of Cripto protein mediates its localization to the cell membrane
We constructed a mutant Cripto protein lacking the last 16 amino-acids (CriptoDC). As a ®rst experiment, we used the af®nity-puri®ed a -Cripto antibodies in immuno¯uores-cence analysis of unpermeabilized 293T cells transiently overexpressing either full-length Cripto or CriptoDC proteins. Transfection ef®ciency was routinely monitored by cotransfecting cells with a GFP expressing vector ( Fig.  4A H , B H , C H ). A strong immunoreactivity signal was detected at the membrane of cells overexpressing full-length Cripto (Fig. 4A HH ). On the contrary, the mutant CriptoDC protein, which lacks most of the hydrophobic C-terminus domain, was never detected at the cell surface of unpermeabilized cells (Fig. 4B HH ). However, after permeabilization, immunoreactivity was detected inside the cells (Fig. 4C HH ), indicating that the CriptoDC mutant protein had indeed been produced. These results not only con®rm the data obtained on the membrane localization of endogenous Cripto in F9 and ES cells but indicate that the C-terminus hydrophobic domain of Cripto is required for membrane attachment.
To con®rm that the truncated Cripto protein could be ef®ciently translated and secreted into the medium, we performed Western blot experiments of conditioned media from 293T cells transiently transfected with either cripto full-length or criptoDC expression constructs. As predicted, the truncated CriptoDC protein was ef®ciently secreted and accumulated in the conditioned medium ( Fig. 5; panel A) while the full-length Cripto protein was almost undetectable in the cell supernatant (except for a faint band with a slightly lower molecular weight). The presence of comparable levels of the control Plgf protein (DiPalma et al., 1996) in both conditioned media indicated that the results were not due to differences in transfection ef®ciency.
The presence of a potential N-linked glycosylation site close to the N-terminus of Cripto (residues 61±63) had suggested that Cripto is a glycoprotein (Dono et al., 1993) as previously demonstrated for the human CRIPTO protein (Brandt et al., 1994) . Consistent with this hypothesis, treatment of conditioned medium with endo-glycosidase F, which removes N-linked glycosylation, produced a protein that migrated slightly faster on SDS-polyacrylamide gel electrophoresis ( Fig. 5; panel B) .
Enzymatic release of Cripto from the membrane
We assayed the susceptibility of Cripto to cleavage by phosphatidylinositol phospholipase C (PI-PLC).
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Slabelled 293T cells, transiently transfected either with the vector alone or with the construct overexpressing full-length Cripto protein, were treated with 0.1±0.5 U/ml of PI-PLC (Section 4). The conditioned media were then immunoprecipitated using the af®nity-puri®ed a -Cripto antibodies (Fig. 6A ). Conditioned medium of untreated cells contains a small amount of soluble free protein; increasing amounts of PI-PLC caused a progressive release of Cripto protein into the medium. Note that the soluble free Cripto exhibits the same electrophoretic mobility as the PI-PLC-released material. Endo-glycosydase F treatment of the conditioned media from both PI-PLC treated and untreated cells produced a protein that migrated faster on SDS-polyacrylamide gel electrophoresis, thus indicating a very similar or identical size of the two forms (Fig. 6B) .
To determine if the endogenous Cripto expressed in F9 cells also has a GPI membrane anchor, we tested its susceptibility to cleavage by PI-PLC. Both F9 and Cripto 2/2 H32 cell lines were treated with 0.2 U/ml of PI-PLC after which the conditioned medium was analysed by Western blot ( Fig.  6 ; panel C). The supernatant of F9 cells generated by PI-PLC treatment contained a signi®cantly higher amount of free soluble Cripto, as compared to untreated media, show- Fig. 2 . Spatial distribution of cripto mRNA and protein in transverse sections of 6.7 and 8.5 dpc mouse embryos. Cripto protein distribution is determined by immunostaining, indicated by the brown colour, in transverse sections from 6.7 dpc wild-type (D,G,H) and cripto 2/2 homozygous (E) and 8.5 dpc wild-type (F,I) embryos. The blue counterstain is haematoxylin. Confocal microscopy of a-Cripto stained 6.7 dpc embryo (H). Dark ®elds show cripto gene expression revealed by in situ hybridization on sections of 6.7 dpc (A) and 8.5 dpc wild-type (C) and of 6.7 dpc cripto 2/2 (B) embryos as determined by in situ hybridization on sections adjacent to those used for the immunostaining. ing that endogenous Cripto is also GPI-anchored. According to the results obtained in transfection experiments (see above and Fig. 6A ), even in F9 cells the soluble free Cripto exhibits the same electrophoretic mobility as the PI-PLCreleased material (Fig. 6C) .
Discussion
During murine development, cripto mRNA is present in the epiblast immediately prior to the onset of gastrulation (Johnson et al., 1994) , and in the cells of the forming mesoderm during all the gastrula stages (Dono et al., 1993; Ding et al. 1998) . Later in development, cripto transcripts are present only in the truncus arteriosus of the developing heart (Dono et al., 1993) . In the present paper we have used immunopuri®ed a -Cripto antibodies to show that cripto mRNA and Cripto protein colocalize during gastrulation and during the later stages of mouse development.
We tested the possibility that Cripto could be a membrane-bound protein as suggested by its predicted sequence. Our studies demonstrate that Cripto is located extracellularly and that it is bound to the cytoplasmic membrane through a GPI-anchor. The release of Cripto from the membrane by digestion with PI-PLC has two possible interpretations: (1) Cripto is bound to a GPI-anchored protein that is released by the PI-PLC digestion; (2) Cripto is itself a GPI-anchored protein. Transfection experiments where Cripto is overexpressed tend to exclude the ®rst possibility because the protein synthesized is retained on the membrane and then released by the enzymatic treatment. In addition, the involvement of the C-terminus in this anchorage is demonstrated by the absence of the truncated protein on the membrane of the transfected cells.
We suggest that the anchorage of Cripto to the membrane by a GPI-linkage is important in determining the spatial identity of cell±cell interactions requested during vertebrate embryo development. In mouse embryos cripto is required for proper anterior±posterior axis polarity (Ding et al., 1998) . Recently the zebra®sh oep gene product, another member of the EGF-CFC family, has been described as a membrane-associated protein with essential and permissive functions during vertebrate development (Zhang et al., 1998) . The phenotypes of cripto and MZ oep mutants show surprising similarities and it has been suggested that vertebrate germ-layer formation and positioning of the ante- rior±posterior axis are controlled by conserved molecular mechanisms involving cripto and oep genes (Gritsman et al., 1999) . Interestingly, the injection of either FRL1 or cripto mRNA rescued the MZ oep mutants, rendering them responsive to Nodal signals and suggesting that at least these members of the EGF-CFC family have common in vivo speci®cities (Gritsman et al., 1999) . Oep has been proposed to act as a cofactor for Nodal signals, much as GFRa 1 protein mediates glial cell line-derived neurotrophic factor (GDNF) signalling (Jing et al., 1996) . Both Oep and GFRa1 are membrane-attached proteins and are required extracellularly for the activity of an instructive signal (Gritsman et al., 1999) . Extending this hypothesis, we have now shown not only that Cripto is a membranebound protein but that it is also GPI-anchored as is GFRa1 (Treanor et al., 1996) . We suggest that a``short-range'' signalling of the membrane-anchored Cripto could account for its cell-autonomous role in rescuing the zebra®sh maternal zygotic oep mutants (Gritsman et al., 1999) . We suggest that the GPI lipid tail of Cripto ensures a tight localization of Cripto in a manner similar to that of the Ephrins A. These are a family of GPI-anchored ligands that bind to the Eph family receptor tyrosine kinases and require membraneanchorage to cluster ef®ciently and activate receptor signalling (Davis et al., 1994; Holder and Klein, 1999) .
In cultured cells, Cripto can be detected both as a soluble free protein in the media and as a GPI-anchored form on the cell membrane. Hydrolysis of GPI-anchored proteins has been postulated to be a regulatory mechanism since a decreased expression of certain GPI-anchored proteins, such as TAG-1 and Fasciclin I, has been observed during development (Furley et al., 1990; Hortsch and Goodman, 1990) . It has recently been demonstrated that a secreted form of Oep could function non-autonomously in rescuing maternal zygotic oep mutants in zebra®sh (Gritsman et al., 1999) . It has thus been suggested that EGF-CFC activity might be regulated by cleavage in a way similar to that described for the Drosophila EGF-related protein spitz (Zhang et al., 1998) . Interestingly, although spitz is produced as a transmembrane protein, it has been shown that it is tightly regulated by cleavage and release from the membrane (Schweitzer and Shilo, 1997; Stevens, 1998) .
From previous data (Kinoshita et al., 1995; Zhang et al., 1998) and our present results, all the members of the EGF-CFC family, except the mouse Cryptic, have been shown to be membrane-anchored proteins. However, experiments performed on Cryptic-Alkaline phosphatase chimeric proteins have argued against a transmembrane form of Cryptic despite the presence of a C-terminus hydrophobic domain and a GPI consensus sequence (Shen et al., 1997) . These data could indicate that both soluble and membraneanchored proteins coexist in the EGF-CFC family. Our evidence for a GPI modi®cation of Cripto raises the question if this is a functional characteristic shared by all the membrane-bound EGF-CFC proteins.
The signals and receptors interacting with the Cripto protein still remain elusive. In vitro studies on mouse mammary epithelial cells have suggested that Cripto protein 35 S methionine/cysteine as described in Section 4. Cell free supernatants of either control and PI-PLC-treated culture (0.1 U/ml and 0.5 U/ml, respectively) were immunoprecipitated using immunopuri®ed a -Cripto antibody. (B) Immunoprecipitation of 35 S-labelled conditioned medium, treated with N-glycosidase F or untreated. (C) Western blot analysis of PI-PLC-generated F9 and cripto 2/2 H32 supernatants. The supernatant of both control or PI-PLC-treated F9 and cripto 2/2 H32 cells (0.2 U/ml) was ®ltered and concentrated by precipitation with acetone. Proteins were electrophoresed on 15% SDS-PAGE and Western blotting was done using immunopuri®ed a-Cripto.
acts as a nonautonomous signal leading to Ras/Raf/MEK/ MAPK activation Salomon et al., 1999) . However, recent in vivo results have suggested that Cripto does not act as an instructive signal in MAPK signalling but rather the addition of Cripto protein renders cells competent to respond to an instructive signal such as Nodal or another TGFb ligand (Gritsman et al., 1999) . Chimeric embryos of wt and Cripto 2/2 ES cells develop normally and both cell types are present in adult tissues, suggesting that mutant cells can differentiate into all tissues and that normal cells can rescue the mutant phenotype (Xu et al., 1999) . Our ®nding that Cripto is GPI-anchored could suggest a juxtacrine activity of its membrane attached form.
Materials and methods

Cripto expression plasmids
To obtain the cripto eukaryotic expression vector, a TaqI/ EcoRI DNA fragment spanning nucleotide 26 to 1531 of the cripto cDNA (Dono et al., 1993) was cloned into the EcoRI site of the pCDNA3 vector (Invitrogen). When necessary, restriction sites were blunt-ended using Klenow polymerase. The criptoD C (Cripto with stop codon at 1156) expressing vector was obtained by PCR, using the complete cripto cDNA as template and, as primers, two synthetic oligonucleotides: the ®rst, GM1 (5 H -CGAA-GATGGGGTACTTCTC-3 H ) was identical to the sequence from nucleotide 25 to 114 of the cripto cDNA (Dono et al., 1993) ; the second, GM2 (5 H -CTAAGTGGTCGTCACA-GAC-3 H ) was complementary to the cripto cDNA sequence from nucleotides 455±472 (Dono et al., 1993) , except for two additional nucleotides introduced to create the stop codon; the ATG and the TAG codons are in italics. PCR products were cloned into a TA cloning vector (Invitrogen) to obtain pTA-criptoD C. The BamHI/XhoI fragment from pTA-criptoD C was subcloned into pCDNA3 (Invitrogen) to obtain criptoD C expression driven by the CMV enhancerpromoter sequence.
To synthesize a GST-Cripto fusion protein in bacteria, we constructed a prokaryotic expression plasmid named pGEXCripto, obtained by cloning a Cripto cDNA fragment synthesized by PCR into the pGEX2T vector (Invitrogen). We used the complete cripto cDNA as template and two oligonucleotide primers; the ®rst was identical to the cDNA (5 H -CCGGGATCCGTACGCGATCGGTCTTTCC-3 H ) from nucleotides 1123 to 1143 except for the addition of a BamHI site (in italics), while the second (5 H -GGGATT-CACTGTGAGCATCAAGA-3 H ) was complementary to the sequence of the cripto cDNA from 1563 to 1585. The PCR synthesized fragment, digested with BamHI and EcoRI restriction enzymes, was cloned into the corresponding sites of pGEX2T vector. In each case the ampli®ed fragments were sequenced in both directions by the dideoxynucleotide method (Hattori and Sakaki, 1986) .
Cell cultures and transfections
The cell types used are: human embryonal kidney cells (293T; DuBridge et al., 1987) , mouse teratocarcinoma F9 and cripto 2/2 (Xu et al., in preparation) F9-derived H32 cells (Coll et al., 1995) . HM1-ES cells (kindly provided by Dr D. Acampora) were grown according to Robertson (1987) . All the other cell lines were grown at 378C in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% foetal calf serum (FCS) in a humidi®ed atmosphere of 5% CO 2 /95% air. Cell lysates were prepared as previously described (Brandt et al., 1994) . The 293T cells were transfected at 50% con¯uence by the calcium phosphate method (Ausubel et al., 1998) using 10 mg of plasmid DNA. Forty-eight hours after transfection, the cells were rinsed twice with phosphate-buffered saline (PBS) and incubated with DMEM without FCS for an additional 20 h. This conditioned medium was used as a source of unlabelled Cripto protein. To obtain labelled Cripto, cells were split and seeded into 6-well tissue culture plates 24 h after transfection. Twenty-four hours later, cells were starved by overnight incubation with Eagle's minimal essential medium (EMEM) without methionine and cysteine and supplemented with 5% dialysed FCS. Subsequently, the medium was replaced by fresh EMEM supplemented with 5% dialysed FCS, containing 100 mCi/ml PRO-MIX [ 
Enzyme treatments and Western blot
Cells grown in monolayer cultures were washed with PBS and then treated with PI-PLC (Sigma; cat. #P8804) at the indicated concentrations, at 378C for 90 min. At the end of this incubation, the cell-free medium was collected and divided in aliquots for further treatment. N-glycosidase F (Boehringer Mannhein; cat. #903-337) reactions were carried out on 200 ml of the conditioned medium of 293T transfected cells according to the manufacturer's protocol (Boehringer Mannhein). Western analysis was performed by blotting onto PVDF membranes (Amersham International); detection of Cripto and Plgf proteins by a-Cripto and a -Plgf antibodies and HPRT-conjugated goat antirabbit secondary antibodies (Bio-Rad Laboratories) were revealed using the ECL system (Amersham International).
Immunoprecipitation and¯uorography
Immunoprecipitation assays were performed on conditioned medium from transfected and labelled 293T cells using the immunopuri®ed a -Cripto antibodies at a concentration of 10 mg/ml in 0.1% Triton X-100. After incubation at 48C for 1 h, the immunocomplexes were collected by incubation with protein A-Sepharose 4B beads (Pharmacia) overnight at 48C. The recovered immunoprecipitates were rinsed 4 times in cold NET buffer (50 mM Tris±HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 0.1% NP40, 0.25% gelatin, 0.02% sodium azide), resuspended in 20 ml of SDS/b-mercaptoethanol sample buffer (Laemmli, 1970) , boiled for 5 min and centrifuged for 5 min. After electrophoresis on SDS 15% polyacrylamide and 10% glycerol gel, the gel was treated with the¯uorographic reagent Amplify (Amersham Corp.), dried and exposed to X-Omat AR ®lm (Kodak) overnight.
Production of bacterial Cripto and anti-Cripto antibodies
The procedure used for bacterial culture and cell lysate preparations was as described (Harlow and Lane, 1988) . pGEX2T and pGEX-Cripto plasmids were used to transform BL21 bacterial strain (Promega). After electrophoresis of lysates on preparative SDS 12% polyacrylamide gel, the GST-Cripto fusion protein was electroeluted using`E lutrap'' (Schleicher and Schuell). Rabbits were injected subcutaneously with 500 mg of recombinant GST-Cripto in Freund's complete adjuvant at 3-week intervals. Antisera were applied to a 5-ml af®nity column coupled with 10 mg of recombinant GST-Cripto fusion protein. Bound IgGs were eluted by a 0.2 M glycine solution (pH 2.5), immediately neutralized using Tris pH 8 and extensively dialysed against PBS 1£.
Embryo genotyping
Staging of embryos was done according to standard criteria (Downs and Davies, 1993) ; 0.5 dpc was considered to be the middle of the day of the copulatory plug. Embryos were genotyped by in situ hybridization using both Cripto and Neo antisense probes.
In situ hybridization and immunohistochemistry
In situ hybridization was carried out as previously described (Dono et al., 1993) . For immunohistochemistry assays, immunopuri®ed a -Cripto antibodies were applied overnight at 48C in a humidi®ed chamber in 100 mM sodium phosphate (pH 7.5), 0.5 M NaCl, 0.5% Triton X-100 and 10% normal goat serum at 1:100 dilution. Slides were washed twice for 5 min each in PBS, then incubated with biotinylated secondary antibody in the same buffer for 1 h at room temperature, followed by two washes in PBS. We routinely ampli®ed the signal by using Biotin/Streptavidin complex (AB complex; Vectastain). The images were processed in AdobePhotoshop 3.05 (Adobe System Inc., Mountain View, CA).
Immuno¯uorescence assay
For immuno¯uorescence, cells were plated on 0.2% gelatin-coated coverslips. Cells were ®xed in 4% paraformaldehyde in PIPES buffer (0.4 M PIPES pH 6.8, 0.5 M EGTA, 1 M MgCl 2 ) for 30 min; blocked with 0.2% BSA in PBS for 10 min and washed twice in PBS. Primary immunopuri®ed a -Cripto antibodies were applied at a dilution of 1:150 in 1% BSA, 10% NGS in PBS for 1 h in a humidi®ed chamber.
Cells were then washed twice in PBS and incubated with rhodamine-conjugated goat anti-rabbit IgG secondary antibodies at a 1:400 dilution (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA) in the same buffer for 1 h followed by two washes in PBS. DNA staining was performed by a 5-min incubation in PBS containing 1 mg/ ml DAPI (4 H ,6-diami-dino-2-phenylindole) followed by extensive washes in PBS. All the treatments were performed at room temperature. Stained cells were mounted in Mowiol (Polyscience, Inc.; cat. #17951) and analysed with conventional epi¯uorescence. Immuno¯uorescence on embryo sections were performed essentially as described above except that Rodamin Avidin D (Vector Laboratories; cat. #A2002) was used. Stained sections were mounted in PBS/glycerol and analysed with a Zeiss laser confocal microscope attached to a Zeiss Axiofot microscope (Carl Zeiss, Oberkochen, Germany). The images were processed in AdobePhotoshop 3.05 (Adobe System Inc., Mountain View, CA).
